Biotechnology Focus Podcast

Welcome to another episode of Biotechnology Focus radio – I am your host Michelle Currie. This week I will share with you an interesting article that I came across and then we will move on to the foremost part of the episode with Vatche Bartekian, here to tell us about his upcoming conference.      It was a work in progress, but after eight long years neuroscientists at the University of Montreal discovered a molecular mechanism that helps make sense of how Lou Gehrig’s disease, or amyotrophic lateral sclerosis (ALS), works.  This discovery could lead to a valuable new treatment in the fight to cure this crippling disease.  Amyotrophic Lateral Sclerosis is a disease that gradually paralyzes people because the brain is no longer able to communicate with the muscles of the body that we are typically able to move at will. Over time, as the muscles of the body break down, someone living with ALS will lose the ability to walk, talk, eat, swallow, and eventually breathe.  While studies such as this do n